{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:13:29Z","timestamp":1740140009119,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T00:00:00Z","timestamp":1598745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T00:00:00Z","timestamp":1598745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001721","name":"University of Groningen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Norepinephrine is a potent \u03b1-sympathomimetic drug which plays an important role in the acute treatment of hypotension and shock. Commercially available norepinephrine solutions contain sodium metabisulfite (Na2S2O5) as an antioxidant. However, prefilled cyclic olefin polymer syringes are not compatible with sodium metabisulfite. The aim of this study was to develop a new formulation of 0.1-mg\/mL norepinephrine solution without sodium metabisulfite which is chemically stable and sterile and can be stored in prefilled polymer syringes. Formulation studies were performed with 0.1-mg\/mL norepinephrine solution with 0, 0.05, or 0.1% ascorbic acid added as antioxidant. The syringes were filled under nitrogen gassing, stored at 20\u2009\u00b1\u20095\u00b0C, and protected from daylight. Based on the formulation test results, the final formulation was defined and stability testing at 20\u2009\u00b1\u20095\u00b0C was performed measuring norepinephrine concentration, pH, clarity, color of the solution, subvisible particles, and sterility at time intervals up to 12\u00a0months. The norepinephrine concentrations at <jats:italic>t<\/jats:italic>\u2009=\u200922\u00a0weeks were 100.4%, 95.4%, and 92.2% for the formulations with no ascorbic acid and with 0.05% and 0.10% ascorbic acid, respectively. Three batches for the stability study were produced containing norepinephrine, sodium edetate, sodium chloride, and water for injections filled under nitrogen gassing and stored at 20\u2009\u00b1\u20095\u00b0C. Norepinephrine concentrations were respectively 98.8%, 98.6%, and 99.3% for batches 1, 2, and 3 at <jats:italic>t<\/jats:italic>\u2009=\u200912\u00a0months. It can be concluded that norepinephrine (0.1\u00a0mg\/mL) solution without metabisulfite is stable for at least 12\u00a0months at room temperature when protected from daylight.<\/jats:p>","DOI":"10.1208\/s12249-020-01784-z","type":"journal-article","created":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T15:02:30Z","timestamp":1598799750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prefilled Cyclic Olefin Sterilized Syringes of Norepinephrine Injection Solution Do Not Need to Be Stabilized by Antioxidants"],"prefix":"10.1208","volume":"21","author":[{"given":"Karin H. M.","family":"Larmen\u00e9- Beld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"van Berkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rommert","family":"Wijnsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Taxis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henderik W.","family":"Frijlink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,30]]},"reference":[{"issue":"2","key":"1784_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1345\/aph.1R147","volume":"47","author":"RN Keers","year":"2013","unstructured":"Keers RN, Williams SD, Cooke J, Ashcroft DM. Prevalence and nature of medication administration errors in health care settings: a systematic review of direct observational evidence. Ann Pharmacother. 2013;47(2):237\u201356.","journal-title":"Ann Pharmacother"},{"issue":"11","key":"1784_CR2","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00228-003-0689-9","volume":"59","author":"K Taxis","year":"2004","unstructured":"Taxis K, Barber N. Incidence and severity of intravenous drug errors in a German hospital. Eur J Clin Pharmacol. 2004;59(11):815\u20137.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"1784_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1503\/cmaj.061743","volume":"178","author":"CS Parshuram","year":"2008","unstructured":"Parshuram CS, To T, Seto W, Trope A, Koren G, Laupacis A. Systematic evaluation of errors occurring during the preparation of intravenous medication. CMAJ. 2008;178(1):42\u20138.","journal-title":"CMAJ"},{"issue":"4","key":"1784_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/qshc.2008.029785","volume":"19","author":"SE McDowell","year":"2010","unstructured":"McDowell SE, Mt-Isa S, Ashby D, Ferner RE. Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysis. Qual Saf Health Care. 2010;19(4):341\u20135.","journal-title":"Qual Saf Health Care"},{"key":"1784_CR5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ijnurstu.2015.08.012","volume":"53","author":"S Berdot","year":"2016","unstructured":"Berdot S, Roudot M, Schramm C, Katsahian S, Durieux P, Sabatier B. Interventions to reduce nurses\u2019 medication administration errors in inpatient settings: a systematic review and meta-analysis. Int J Nurs Stud. 2016;53:342\u201350.","journal-title":"Int J Nurs Stud"},{"key":"1784_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1136\/ejhpharm-2015-000709","volume":"23","author":"H Scheepers","year":"2016","unstructured":"Scheepers H, Beaney AM, Le Brun PPH, Veerup Handlos V, Schutjens M, Walser S, et al. Aseptic preparation of parenteral medicinal products in healthcare establisments in Europe. Eur J Hosp Pharm Sci Pract. 2016;23:50\u20133.","journal-title":"Eur J Hosp Pharm Sci Pract"},{"key":"1784_CR7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1136\/ejhpharm-2016-001017","volume":"24","author":"H Scheepers","year":"2017","unstructured":"Scheepers H, Neerup Handlos V, Walser S, Schutjens M, Neef C. Impact of the Council of Europe Resolution on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients. Eur J Hosp Pharm Sci Pract. 2017;24:218\u201323.","journal-title":"Eur J Hosp Pharm Sci Pract"},{"issue":"8","key":"1784_CR8","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00228-018-2471-z","volume":"74","author":"K Larmen\u00e9-Beld","year":"2018","unstructured":"Larmen\u00e9-Beld K, Alting E, Taxis K. A systematic literature review on strategies to avoid look-alike errors of labels. Eur J Clin Pharmacol. 2018;74(8):985\u201393.","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"1784_CR9","first-page":"798","volume":"37","author":"R Grunert","year":"1982","unstructured":"Grunert R, Wollmann H. Effect of ultraviolet and visible light on drugs of the phenylalkylamine series with a view toward their stability in plastic containers. 17. Stability of drugs and preparations. 83. Problems of the use of plastic containers for liquid pharmaceuticals. Pharmazie. 1982;37(11):798\u20139.","journal-title":"Pharmazie"},{"issue":"1\u20132","key":"1784_CR10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.ijpharm.2012.05.017","volume":"434","author":"L Hoellein","year":"2012","unstructured":"Hoellein L, Holzgrabe U. Ficts and facts of epinephrine and norepinephrine stability in injectable solutions. Int J Pharm. 2012;434(1\u20132):468\u201380.","journal-title":"Int J Pharm"},{"key":"1784_CR11","volume-title":"Handbook on injectable drugs","author":"LA Trissel","year":"2013","unstructured":"Trissel LA. Handbook on injectable drugs. 17th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2013.","edition":"17"},{"issue":"3","key":"1784_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3109\/10408448709071208","volume":"17","author":"AF Gunnison","year":"1987","unstructured":"Gunnison AF, Jacobsen DW. Sulfite hypersensitivity. A critical review. CRC Crit Rev Toxicol. 1987;17(3):185\u2013214.","journal-title":"CRC Crit Rev Toxicol"},{"issue":"10","key":"1784_CR13","first-page":"2220","volume":"42","author":"MF Dalton-Bunnow","year":"1985","unstructured":"Dalton-Bunnow MF. Review of sulfite sensitivity. Am J Hosp Pharm. 1985;42(10):2220\u20136.","journal-title":"Am J Hosp Pharm"},{"key":"1784_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13223-019-0324-7","volume":"15","author":"HG Parish","year":"2019","unstructured":"Parish HG, Morton JR, Brown JC. A systematic review of epinephrine stability and sterility with storage in a syringe. Allergy Asthma Clin Immunol. 2019;15:7\u20137 eCollection 2019.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"1784_CR15","unstructured":"Committee for Human Medicinal Products. ICH Q8 (R2) Pharmaceutical development. 2017; Available at: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en-19.pdf. Accessed 03\u201312-, 2019."},{"key":"1784_CR16","first-page":"3","volume-title":"ICHQ1A(R2) Stability testing of new drug substance and product and ICHQ1C stability testing of new dosage forms. ICH Quality Guidelines","author":"A Rignall","year":"2017","unstructured":"Rignall A. ICHQ1A(R2) Stability testing of new drug substance and product and ICHQ1C stability testing of new dosage forms. ICH Quality Guidelines. Hoboken: John Wiley & Sons, Inc; 2017. p. 3\u201344."},{"issue":"Suppl 1","key":"1784_CR17","first-page":"A56","volume":"26","author":"K Larmen\u00e9- Beld","year":"2019","unstructured":"Larmen\u00e9- Beld K, Wijnsma R, Kuiper A, Van Berkel S, Robben H, Taxis K, et al. 3PC-042A science- and risk-based strategy to qualify sterilised prefilled syringes as primary packaging material in a hospital pharmacy. Eur J Hosp Pharm. 2019;26(Suppl 1):A56.","journal-title":"Eur J Hosp Pharm"},{"issue":"2","key":"1784_CR18","first-page":"136","volume":"54","author":"J Brustugun","year":"2000","unstructured":"Brustugun J, Tonnesen HH, Klem W, Kjonniksen I. Photodestabilization of epinephrine by sodium metabisulfite. PDA J Pharm Sci Technol. 2000;54(2):136\u201343.","journal-title":"PDA J Pharm Sci Technol"},{"issue":"4","key":"1784_CR19","first-page":"226","volume":"32","author":"I Wolf","year":"2011","unstructured":"Wolf I, Scherbel G. AKTUELLES AUS DER REZEPTUR-Adrenalin-und Noradrenalin-Verd\u00fcnnungen-Physikalisch-chemische und mikrobiologische Stabilit\u00e4t. Krankenhauspharmazie. 2011;32(4):226.","journal-title":"Krankenhauspharmazie"},{"issue":"4","key":"1784_CR20","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/ejhpharm-2012-000068","volume":"19","author":"D Zenoni","year":"2012","unstructured":"Zenoni D, Priori G, Bellan C, Invernizzi RW. Stability of diluted epinephrine in prefilled syringes for use in neonatology. Eur J Hosp Pharm Sci Pract. 2012;19(4):378\u201380.","journal-title":"Eur J Hosp Pharm Sci Pract"},{"key":"1784_CR21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0021-9673(01)93185-1","volume":"518","author":"DL Palazzolo","year":"1990","unstructured":"Palazzolo DL, Quadri SK. Optimal conditions for long-term storage of biogenic amines for subsequent analysis by column chromatography with electrochemical detection. J Chromatogr A. 1990;518:258\u201363.","journal-title":"J Chromatogr A"},{"key":"1784_CR22","first-page":"113","volume":"110","author":"H Cox","year":"1975","unstructured":"Cox H, Boer Y. Toelichting bij aanvulling 9 van het FNA. Pharm Weekbl. 1975;110:113\u20137.","journal-title":"Pharm Weekbl"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-020-01784-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-020-01784-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-020-01784-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,29]],"date-time":"2021-08-29T23:05:21Z","timestamp":1630278321000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-020-01784-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,30]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1784"],"URL":"https:\/\/doi.org\/10.1208\/s12249-020-01784-z","relation":{},"ISSN":["1530-9932"],"issn-type":[{"type":"electronic","value":"1530-9932"}],"subject":[],"published":{"date-parts":[[2020,8,30]]},"assertion":[{"value":"20 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"247"}}